Managing the Emotions of Metastatic Breast Cancer When You’re Young
This podcast is the audio from a special Virtual Support Group featuring guest moderator Kelly Grosklags.
Listen to the podcast to hear Kelly and Community members discuss:
why you might not want to share tough emotions with the people in your life
how to tell someone you need them to listen, not fix things
how different members of the group shared their diagnosis with family and friends
--------
58:32
--------
58:32
Breast Cancer Doesn’t Care Whom You Love
Four years after giving birth to her son, Jaci Field was diagnosed with breast cancer at age 39.
Listen to the episode to hear Jaci discuss:
her breast cancer experience and her advocacy work
the discrimination she’s faced, both because of her race and whom she chooses to love
how she finds joy
--------
20:25
--------
20:25
Managing Hormonal Therapy Side Effects
At the 2025 American Society of Clinical Oncology Annual Meeting, Hope Rugo, MD, chaired a session on managing the side effects of new breast cancer treatments and also presented information on how to manage the side effects of hormonal therapy medicines, which are used to treat hormone receptor-positive breast cancer.
Listen to the episode to hear Dr. Rugo explain:
ways to manage the side effects of tamoxifen and the aromatase inhibitors
why talking to your doctor about side is crucial to managing them
her advice for people who are having side effects from hormonal therapy medicines
--------
29:25
--------
29:25
Financial Toxicity and Breast Cancer: How Doctors Can Help
At the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting Fumiko Chino, MD, summarized her presentation on how doctors can help the people they care for overcome financial issues. She also offered some strategies for patients.
Listen to the podcast to hear Dr. Chino explain:
some specific resources for people with cancer
why people with breast cancer may have the most financial issues
her top three recommendations for people having financial hardship
--------
13:55
--------
13:55
Top Breast Cancer Research at ASCO 2025
The 2025 American Society of Clinical Oncology (ASCO) Annual Meeting featured five days of presentations and educational sessions on all types of cancer. Dr. Eleonora Teplinsky, a board-certified medical oncologist at the Valley-Mount Sinai Comprehensive Cancer Center in Paramus, NJ, summarizes the top breast cancer research.
Listen to the episode to hear Dr. Teplinsky discuss:
The SERENA-6 trial, which found that if metastatic hormone receptor-positive, HER2-negative breast cancer develops ESR1 mutations during first hormonal therapy treatment, switching to camizestrant from an aromatase inhibitor before the cancer grows improves outcomes.
Results from the DESTINY-Breast09 trial showing that the combination of Enhertu (chemical name: fam-trastuzumab-deruxtecan-nxki) and Perjeta (chemical name: pertuzumab) is a better first treatment for metastatic HER2-positive breast cancer than the current standard of THP chemo.
The ASCENT-04/KEYNOTE-D19 trial, which found that people with metastatic, PD-L1-positive, triple-negative breast cancer fared better with the combo of Trodelvy (chemical name: sacituzumab govitecan-hziy) and Keytruda (chemical name: pembrolizumab) as a first treatment compared to people who received chemotherapy and Keytruda.
Breastcancer.org is a nonprofit organization dedicated to providing the most reliable, complete, and up-to-date information about breast cancer. Our mission is to help women and their loved ones make sense of the complex medical and personal information about breast cancer, so they can make the best decisions for their lives. Breastcancer.org podcasts offer unique insights on prevention, treatment, research, and other breast cancer topics from our medical experts and invited guests.
New Zealand